{"title":"睾酮缺乏及治疗对男性心脏代谢综合征的影响。","authors":"Farid Saad DVM, PhD , Abdulmaged M Traish PhD","doi":"10.1016/j.amjms.2025.08.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Testosterone (T) is a metabolic, sexual, and vascular hormone that has an important metabolic function in many tissues and organs and plays a key role in maintaining human physiology and health. A deficiency of T has detrimental effects on men’s health and negatively impacts quality of life. T regulates differentiation, growth and function of muscle tissue and inhibits differentiation into adipocytes and fat accumulation; therefore, it regulates body composition. Thus, T deficiency (TD) may contribute to development of adiposity and metabolic syndrome (MetS). It should be noted that over the past 80 years, only 4 randomized clinical trials with a duration of three years or longer were reported. Hence, understanding the effects of long-term T therapy (TTh) on amelioration of MetS and its components would be attained mostly from observational and registry studies.</div></div><div><h3>Methods</h3><div>A comprehensive review of the current literature utilizing the NCBI library and PubMed were utilized using the key words “metabolic syndrome; testosterone deficiency; testosterone therapy”. Relevant articles were retrieved and a summary of the potential relationship between TD and TTh and MetS were synthesized.</div></div><div><h3>Results</h3><div>The contemporary findings in the medical literature strongly suggest that TD is a predictor of onset of MetS and TTh ameliorates MetS components. Long-term data from several registry studies on the impact of TTh on MetS in men with TD demonstrated unequivocally that long-term TTh (up to 11 years) resulted in reductions in waist circumference (WC), fasting blood glucose, triglycerides (TGs), systolic and diastolic blood pressure and increased high-density lipoprotein cholesterol (HDL). In summary, long-term TTh in men with TD: 1) produces substantial and sustained weight loss; 2) prevents the progression from prediabetes to type 2 diabetes; 3) may result in remission of type 2 diabetes; 4) reduces fasting blood glucose; and 5) reduces cardiovascular events and mortality.</div></div><div><h3>Conclusions</h3><div>In this narrative review, we summarize the available contemporary literature on the potential relationship between TD and development of MetS and discuss the findings of long-term TTh on amelioration of MetS components in men.</div></div>","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"370 5","pages":"Pages 409-419"},"PeriodicalIF":1.8000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of testosterone deficiency and therapy on the cardiometabolic syndrome in men\",\"authors\":\"Farid Saad DVM, PhD , Abdulmaged M Traish PhD\",\"doi\":\"10.1016/j.amjms.2025.08.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Testosterone (T) is a metabolic, sexual, and vascular hormone that has an important metabolic function in many tissues and organs and plays a key role in maintaining human physiology and health. A deficiency of T has detrimental effects on men’s health and negatively impacts quality of life. T regulates differentiation, growth and function of muscle tissue and inhibits differentiation into adipocytes and fat accumulation; therefore, it regulates body composition. Thus, T deficiency (TD) may contribute to development of adiposity and metabolic syndrome (MetS). It should be noted that over the past 80 years, only 4 randomized clinical trials with a duration of three years or longer were reported. Hence, understanding the effects of long-term T therapy (TTh) on amelioration of MetS and its components would be attained mostly from observational and registry studies.</div></div><div><h3>Methods</h3><div>A comprehensive review of the current literature utilizing the NCBI library and PubMed were utilized using the key words “metabolic syndrome; testosterone deficiency; testosterone therapy”. Relevant articles were retrieved and a summary of the potential relationship between TD and TTh and MetS were synthesized.</div></div><div><h3>Results</h3><div>The contemporary findings in the medical literature strongly suggest that TD is a predictor of onset of MetS and TTh ameliorates MetS components. Long-term data from several registry studies on the impact of TTh on MetS in men with TD demonstrated unequivocally that long-term TTh (up to 11 years) resulted in reductions in waist circumference (WC), fasting blood glucose, triglycerides (TGs), systolic and diastolic blood pressure and increased high-density lipoprotein cholesterol (HDL). In summary, long-term TTh in men with TD: 1) produces substantial and sustained weight loss; 2) prevents the progression from prediabetes to type 2 diabetes; 3) may result in remission of type 2 diabetes; 4) reduces fasting blood glucose; and 5) reduces cardiovascular events and mortality.</div></div><div><h3>Conclusions</h3><div>In this narrative review, we summarize the available contemporary literature on the potential relationship between TD and development of MetS and discuss the findings of long-term TTh on amelioration of MetS components in men.</div></div>\",\"PeriodicalId\":55526,\"journal\":{\"name\":\"American Journal of the Medical Sciences\",\"volume\":\"370 5\",\"pages\":\"Pages 409-419\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of the Medical Sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0002962925011383\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of the Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002962925011383","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Effects of testosterone deficiency and therapy on the cardiometabolic syndrome in men
Background
Testosterone (T) is a metabolic, sexual, and vascular hormone that has an important metabolic function in many tissues and organs and plays a key role in maintaining human physiology and health. A deficiency of T has detrimental effects on men’s health and negatively impacts quality of life. T regulates differentiation, growth and function of muscle tissue and inhibits differentiation into adipocytes and fat accumulation; therefore, it regulates body composition. Thus, T deficiency (TD) may contribute to development of adiposity and metabolic syndrome (MetS). It should be noted that over the past 80 years, only 4 randomized clinical trials with a duration of three years or longer were reported. Hence, understanding the effects of long-term T therapy (TTh) on amelioration of MetS and its components would be attained mostly from observational and registry studies.
Methods
A comprehensive review of the current literature utilizing the NCBI library and PubMed were utilized using the key words “metabolic syndrome; testosterone deficiency; testosterone therapy”. Relevant articles were retrieved and a summary of the potential relationship between TD and TTh and MetS were synthesized.
Results
The contemporary findings in the medical literature strongly suggest that TD is a predictor of onset of MetS and TTh ameliorates MetS components. Long-term data from several registry studies on the impact of TTh on MetS in men with TD demonstrated unequivocally that long-term TTh (up to 11 years) resulted in reductions in waist circumference (WC), fasting blood glucose, triglycerides (TGs), systolic and diastolic blood pressure and increased high-density lipoprotein cholesterol (HDL). In summary, long-term TTh in men with TD: 1) produces substantial and sustained weight loss; 2) prevents the progression from prediabetes to type 2 diabetes; 3) may result in remission of type 2 diabetes; 4) reduces fasting blood glucose; and 5) reduces cardiovascular events and mortality.
Conclusions
In this narrative review, we summarize the available contemporary literature on the potential relationship between TD and development of MetS and discuss the findings of long-term TTh on amelioration of MetS components in men.
期刊介绍:
The American Journal of The Medical Sciences (AJMS), founded in 1820, is the 2nd oldest medical journal in the United States. The AJMS is the official journal of the Southern Society for Clinical Investigation (SSCI). The SSCI is dedicated to the advancement of medical research and the exchange of knowledge, information and ideas. Its members are committed to mentoring future generations of medical investigators and promoting careers in academic medicine. The AJMS publishes, on a monthly basis, peer-reviewed articles in the field of internal medicine and its subspecialties, which include:
Original clinical and basic science investigations
Review articles
Online Images in the Medical Sciences
Special Features Include:
Patient-Centered Focused Reviews
History of Medicine
The Science of Medical Education.